ARNity Therapeutics is an innovative French biotech company founded in 2025, with the ambition of treating autoimmune diseases such as asthma and food allergies, by developing active immunotherapy treatments based on mRNA.
Company Details
- Employees
- 2
- Founded
- 2025
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.arnitytx.com
- Keywords
- Asthma, Food Allergy, mRNA, LNP.
Arnity Therapeutics Questions
Arnity Therapeutics's website is http://www.arnitytx.com
Arnity Therapeutics's LinkedIn profile is https://www.linkedin.com/company/arnitytx
Arnity Therapeutics has
2 employees.
View email and phone details for 2
employees at Arnity Therapeutics.
Arnity Therapeutics's industry is
Biotechnology Research
Arnity Therapeutics's top competitors are
Sail Biomedicines,
Valneva,
Startup World Cup,
Therasonic,
Rna Leaders,
Research Quality Association (Rqa),
Jazz Pharmaceuticals,
Euro-Bioimaging,
Lentitek,
Roquette.
Arnity Therapeutics's categories are Biotechnology Research
Arnity Therapeutics's founding year is 2025
